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A prospective study was carried out to assess the incidence and the local antibiotic susceptibility of Pseudomonas
aeruginosa in intensive care units (ICUs) and to characterize cross-transmission by using pulsed-field
gel electrophoresis as an epidemiologic tool. For this purpose, we screened surveillance cultures and routine
clinical cultures from patients admitted to two adult ICUs during a 2-year period. Antibiotic susceptibility
was determined by a disk diffusion method. The overall incidence of P. aeruginosa was 19.1 cases per
100 patients. Our findings concerning the antibiotic resistance of clinical isolates were concordant
with those of other studies. Genotyping revealed that approximately 53.5% of P. aeruginosa colonization
was acquired via cross-transmission; the other cases probably originated from endogenous sources.
Cross-colonization seems to make a large contribution to the spread of P. aeruginosa in ICUs.
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Pseudomonas aeruginosa, a common hospital-acquired pathogen,
is very important because of the number of infections caused
and their gravity [1,2]. Intensive care units (ICUs) are settings of
high endemicity for this pathogen, which commonly causes
bronchopulmonary infections, and less frequently urinary tract
infections, infections of surgical wounds, and bacteremia [3–6].
Nowadays, endemic nosocomial infections are thought to
originate mainly from patients’ endogenous flora [7,8]. We
carried out a prospective study to assess the incidence and the
local antibiotic susceptibility of P. aeruginosa in ICUs and to
characterize cross-transmission by using pulsed-field gel elec-
trophoresis (PFGE) as an epidemiologic tool.
We studied two separate adult units: the medical and surgical
ICUs at the University Hospital, Besanc¸on. Each unit has 15
beds. These two units admit a total of 800 patients per year,
giving a mean of 9500 patient-days per year. All patients
admitted to these two ICUs between 1 January 1998 and 31
December 1999 were included in a prospective study and were
tested for P. aeruginosa. Routine clinical specimens and surveil-
lance specimens (rectal swabs, nasal swabs and tracheal aspira-
tion) were screened for P. aeruginosa. Surveillance samples were
collected from each patient on the day of admission and then
once a week for the duration of hospitalization in the ICU.
The disk diffusion method was used to determine the anti-
biotic susceptibility of the isolates, which were classified as
susceptible, intermediate or resistant according to the criteria of
the Antibiogram Committee of the French Society for Micro-
biology [9].
P. aeruginosa colonization (identified by clinical or surveil-
lance culture) was considered to be ICU acquired if P. aeruginosa
was not detected in any specimen during the first 48 h following
admission to the ICU. Endogenous colonization was defined as
colonization occurring with a strain of P. aeruginosa that had not
previously been isolated from another patient. Exogenous
colonization or cross-colonization was defined as colonization
by a strain of P. aeruginosa with a PFGE pattern identical or very
similar to that of isolates from another patient present in one of
the ICUs.
The genetic similarity of strains was investigated by PFGE
(CHEF DRIII, Bio-Rad, Ivry sur Seine, France) using DraI
(Boehringer, Mannheim, Germany) as previously described
[10]. Samples of SmaI-restricted DNA of Staphylococcus aureus
NCTC 8325 were included in each run as an internal reference.
The banding patterns were analyzed by scanning photographic
negatives. GelCompar software (version 4.1) was used for clus-
ter analysis (Applied Maths, Kortrijk, Belgium). Each strain was
first compared with all other strains, and the Dice correlation
coefficient was used to calculate similarity. The strains were then
grouped and the UPGMA clustering algorithm was used to depict
the groups as a dendrogram. Major restriction patterns were
defined as those differing by more than three fragments, with a
similarity index <85%, as described by Tenover et al. [11].
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During the study period, 1646 patients were admitted to the
ICUs for a total of 19 544 days. One thousand three hundred
and twelve specimens corresponding to 692 non-replicate sites
(clinical and surveillance) of positive isolation tests for P.
aeruginosa were collected from 314 patients (166 of these patients
had positive clinical culture tests and 148 had positive surveil-
lance culture tests only). The overall incidence of P. aeruginosa
was 19.1 cases per 100 patients (17.2 in the SICU and 21.0 in
the MICU) and 16.1 cases per 1000 days of hospitalization. Of
166 patients with at least one positive clinical culture, 69
(41.5%) had positive bronchoalveolar lavage tests and 57
(34.3%) had positive urine tests. The other clinical sites were
superficial wounds, catheters, drainage fluids, and blood
(Table 1). Resistance rates are shown in Table 1.
We typed the initial ICU-acquired isolate from 155 patients
(79 patients from the MICU and 76 from the SICU), randomly
selected. The corresponding 155 non-replicate isolates yielded
71 major DNA patterns: 50 unique patterns, eight patterns
including two isolates, five patterns including three isolates, two
patterns including four isolates, one pattern including five
isolates, three patterns including six isolates, one pattern includ-
ing 10 isolates, and one pattern including 32 isolates. The
outbreak involving the last clone, designated a major epidemic
clone, has been reported previously [12]. It disseminated mostly
in the SICU (28 cases of the 32). The dates of stay, the location
of hospitalization and transfers of patients colonized by any of
the strains of P. aeruginosa with a PFGE pattern including two or
more isolates (21 patterns) are consistent with there being cross-
transmission. Indeed, cross-transmission would have been pos-
sible, in both space and time, for all of these patterns except two.
Eighty-three of the 155 studied cases of colonization (53.5%)
were acquired by cross-transmission, and the 72 other cases
probably originated from endogenous sources. The cross-trans-
mission rates were 48.1% in the MICU and 59.2% in the SICU.
Table 2 shows the association of DNA pattern with antibiotic
susceptibility.
Our study contributes to the knowledge concerning P.
aeruginosa, for which little information is available about inci-
dence and cross-transmission rate (except in epidemic situa-
tions), despite there being extensive published data concerning
its resistance to antibiotics. The relative importance of endo-
genous and exogenous sources of P. aeruginosa is unclear. The
possibility of cross-colonization in non-epidemic situations has
rarely been studied using PFGE, the genomic fingerprinting
method now regarded as the most accurate method for the
typing of P. aeruginosa [10,13–15].
We show that clinical specimens identify only half of the
patients positive for P. aeruginosa. In the absence of a screening
program including surveillance samples, 47.1% (148/314) of all
carriers would have remained undetected. Thus, P. aeruginosa
clinical cultures do not present the full epidemiologic picture.
Comparison of incidence rates between ICUs is difficult,
Table1 Frequency of decreased susceptibility (%þR) of P. aeruginosa isolates in ICUs
Sites of isolation (number) TIC PIP CAZ ATM IPM AMK CIP
Clinical specimens (232) 42.2 26.7 19.4 34.9 34.5 22.8 38.8
Urines (57) 47.4 33.3 28.1 38.6 33.3 17.5 45.6
Bronchoalveolar lavage (69) 33.3 18.8 14.5 21.7 30.4 21.7 26.1
Blood (7) 71.4 57.1 14.3 71.4 28.6 28.6 57.1
Drainage fluid (21) 57.1 47.6 33.3 52.4 47.6 286 57.1
Superficial wounds (39) 43.6 25.6 15.4 38.5 23.1 17.9 35.9
Intravascular catheters (32) 37.5 15.6 15.6 34.4 56.2 40.6 40.6
Others (7) 28.6 14.3 0 28.6 14.3 0 42.9
Surveillance specimens (460) 50.0 29.6 22.6 40.6 23.0 22.8 38.0
Total (692) 47.4 28.6 21.5 38.7 26.9 22.8 38.3
TIC, ticarcillin; PIP, piperacillin; CAZ, ceftazidime; ATM, aztreonam; IPM, imipenem; AMK, amikacin; CIP, ciprofloxacin.
Table 2 Association of DNA pattern with antibiotic resistance for P. aeruginosa strains isolated in ICUs
b-Lactam resistance (%)
PFGEDNA pattern Wild type Ticarcillin I/R Ceftazidime I/R Imipenem I/R
Unique patterna (n¼51) 40 (78.4) 6 (11.8) 2 (3.9) 3 (5.9)
Epidemic patternb (n¼104) 50 (48.1) 42 (40.4) 2 (1.9) 10 (9.6)
Total 90 (58.1) 48 (31.0) 4 (2.6) 13 (8.4)
aPFGE pattern including a single isolate. bPFGE pattern including two or more non-replicate isolates.
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mainly because of differences in patient populations. However,
the incidences of P. aeruginosa colonization upon admission and
during hospitalization in our institution are consistent with
those elsewhere in France [6] and Europe [16,17]. The rate of
colonization upon admission was below 5%, and 74.2% of
colonizations or colonizations/infections were ICU acquired.
Our findings concerning the antibiotic resistance of clinical
isolates are concordant with the French multicenter study of the
GERPB (Workgroup on the resistance of P. aeruginosa to b-
lactam antibiotics) including all types of ward [18], except for
imipenem resistance, which is higher in the ICU (18.5% for the
GERPB versus 34.5% in our study). Moreover, the clinical sites
most frequently associated with infection (bronchoalveolar
lavage, blood, urines, drainage fluids) were not associated with
a higher frequency of resistance. These results suggest that
antibiotic resistance is not associated with virulence. It was
clear that the emergence of antibiotic resistance within the P.
aeruginosa population results from acquisition of resistance by
susceptible strains following selective pressure exerted by anti-
biotics. However, our results show that this spread of resistance
is also a consequence of the diffusion of epidemic multiresistant
strains (Table 2).
Our findings suggest that cross-colonization may be a major
cause of P. aeruginosa colonization and infection in ICUs. We
identified an epidemic clone of P. aeruginosa that persisted for
at least 30 months in the SICU [12]. However, this epidemic
clone led to an overestimate of cross-colonization rate. Exclud-
ing this clone, the rate of cross-transmission is very much lower,
but nevertheless above 40%. The epidemiologic pattern of
P. aeruginosa in ICUs may be described as a silent epidemic,
similar to those of other nosocomial pathogens, such as vanco-
mycin-resistant enterococci. Thus, the situation appears to be a
succession of outbreaks affecting from three to 10 patients,
against a background of sporadic cases. Larger outbreaks may
then add to this underlying epidemiologic pattern [19].
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